Top Back to top

JACIE Standards

The Standards are the cornerstone of the JACIE accreditation program. FACT-JACIE Standards are evidence-based Standards set by international teams of experts working within the field of cellular therapies. The Standards are based upon published medical evidence whenever possible. If no published data is available, the Standards are based on accepted scientific theory. The development process includes a period for public review and comment, a legal review, and an approval by the respective FACT and JACIE Boards.
 

The Standards currently apply to Haematopoietic Progenitor Cells (HPC), nucleated cells or mononuclear cells from any haematopoietic tissue source, as well as to Immune Effector Cells (IEC) and genetically modified cells.

FACT and JACIE Publish the 9th Edition HCT and 3rd Edition IEC Standards for Public Comment

The Foundation for the Accreditation of Cellular Therapy (FACT) and the Joint Accreditation Committee ISCT-Europe & EBMT (JACIE) have published a preliminary draft of both the FACT-JACIE International Standards for Hematopoietic Cellular Therapy Product Collection, Processing, and Administration, Ninth Edition (HCT 9 Standards) and the FACT-JACIE International Standards for Immune Effector Cells, Third Edition (IEC).

These drafts are now open for public comments which will be accepted until 15 December 2024.